Angina reduction after BRSs implantation: Correlation with changes in coronary hemodynamics

Nick E.J. West, Adam John Dunbar Brown, Stephen P. Hoole

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Otherpeer-review

1 Citation (Scopus)

Abstract

Despite huge advances in interventional cardiology, as a specialty we remain rooted in the immediate: most novel devices are assessed at short-term time points with low-frequency clinical endpoints that have to be combined into composites in order to provide a reasonable chance of demonstrating either noninferiority or superiority [1,2]. As far as longer-term patient prognosis goes, percutaneous coronary intervention (PCI) provides at best a modest impact, with benefits largely confined to patients with substantial ischemic burden [3] or acute ST-elevation myocardial infarction [4].

Original languageEnglish
Title of host publicationBioresorbable Scaffolds
Subtitle of host publicationFrom Basic Concept to Clinical Applications
EditorsYoshinobu Onuma, Patrick W.J.C. Serruys
Place of PublicationBoca Raton
PublisherCRC Press
Pages215-223
Number of pages9
ISBN (Electronic)9781498779777
ISBN (Print)9781498779746
DOIs
Publication statusPublished - 1 Jan 2017
Externally publishedYes

Cite this